Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
uTPI: A utility-based toxicity probability interval design for phase I/II dose-finding trials.
Stat Med. 2021 May 20;40(11):2626-2649. doi: 10.1002/sim.8922. Epub 2021 Mar 2.
Stat Med. 2021.
PMID: 33650708
AKT isoform-specific expression and activation across cancer lineages.
Wang J, Zhao W, Guo H, Fang Y, Stockman SE, Bai S, Ng PK, Li Y, Yu Q, Lu Y, Jeong KJ, Chen X, Gao M, Liang J, Li W, Tian X, Jonasch E, Mills GB, Ding Z.
Wang J, et al.
BMC Cancer. 2018 Jul 16;18(1):742. doi: 10.1186/s12885-018-4654-5.
BMC Cancer. 2018.
PMID: 30012111
Free PMC article.
Item in Clipboard
Generalized phase I-II designs to increase long term therapeutic success rate.
Thall PF, Zang Y, Yuan Y.
Thall PF, et al.
Pharm Stat. 2023 Jul-Aug;22(4):692-706. doi: 10.1002/pst.2301. Epub 2023 Apr 11.
Pharm Stat. 2023.
PMID: 37038957
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite